Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan

OBJECTIVE: Botulinum toxin (BT) therapy is a first‐line treatment for spasmodic dysphonia (SD). However, a detailed chronological course and clinical factors that affect the therapeutic effect have been vague. In this study, we analyzed the data from our placebo‐controlled, randomized, double‐blinde...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Kahori, Asano, Kento, Sakaguchi, Masahiko, Nagao, Asuka, Nakahira, Maya, Doi, Nao, Kobayashi, Taisuke, Hyodo, Masamitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Laryngology, Speech and Language Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513418/
https://www.ncbi.nlm.nih.gov/pubmed/34667852
http://dx.doi.org/10.1002/lio2.669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513418/
https://www.ncbi.nlm.nih.gov/pubmed/34667852
http://dx.doi.org/10.1002/lio2.669

Ejemplares similares